The World Market for Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins: A 2009 Global Trade Perspective
ICON Group International, September 2008, Pages: 247
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins? What is the dollar value of these imports? How much do the imports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins, for each individual country. Chapter 4 does the same, but for imports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins (i.e. their market shares are close or equal to zero percent). "Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins" is 54219 .
1 METHODOLOGY 12
1.1 Our Approach 12
2 THE WORLD MARKET 16
2.1 Exports 16
2.1.1 The World Market: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Export Supplies in 2009 16
2.2 Imports 19
2.2.1 The World Market: Imported Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins in 2009 19
3 EXPORTS 23
3.1 Africa: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and 23
3.1.1 Executive Summary 23
3.1.2 Algeria 26
3.1.3 Benin 26
3.1.4 Cote dIvoire 27
3.1.5 Egypt 27
3.1.6 Kenya 28
3.1.7 Mauritius 28
3.1.8 Morocco 28
3.1.9 Senegal 29
3.1.10 Sierra Leone 29
3.1.11 South Africa 29
3.1.12 Tanzania 30
3.1.13 Zimbabwe 30
3.2 Asia: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and 30
3.2.1 Executive Summary 30
3.2.2 Bangladesh 33
3.2.3 China 34
3.2.4 Hong Kong 35
3.2.5 India 36
3.2.6 Indonesia 37
3.2.7 Japan 38
3.2.8 Macau 39
3.2.9 Malaysia 39
3.2.10 North Korea 39
3.2.11 Philippines 40
3.2.12 Singapore 40
3.2.13 South Korea 41
3.2.14 Sri Lanka 41
3.2.15 Taiwan 42
3.2.16 Thailand 42
3.2.17 Vietnam 43
3.3 Europe: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and 43
3.3.1 Executive Summary 43
3.3.2 Austria 48
3.3.3 Belarus 49
3.3.4 Belgium 50
3.3.5 Bosnia and Herzegovina 51
3.3.6 Bulgaria 51
3.3.7 Croatia 52
3.3.8 Cyprus 53
3.3.9 Czech Republic 54
3.3.10 Denmark 55
3.3.11 Estonia 56
3.3.12 Finland 56
3.3.13 France 57
3.3.14 Georgia 58
3.3.15 Germany 59
3.3.16 Greece 60
3.3.17 Hungary 61
3.3.18 Iceland 62
3.3.19 Ireland 63
3.3.20 Italy 64
3.3.21 Kazakhstan 65
3.3.22 Latvia 65
3.3.23 Lithuania 65
3.3.24 Luxembourg 66
3.3.25 Macedonia 66
3.3.26 Malta 66
3.3.27 Moldova 67
3.3.28 Norway 68
3.3.29 Poland 69
3.3.30 Portugal 70
3.3.31 Romania 71
3.3.32 Russia 71
3.3.33 Slovakia 72
3.3.34 Slovenia 73
3.3.35 Spain 74
3.3.36 Sweden 75
3.3.37 Switzerland 76
3.3.38 the Netherlands 77
3.3.39 the United Kingdom 78
3.3.40 Ukraine 79
3.4 Latin America: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and 79
3.4.1 Executive Summary 79
3.4.2 Argentina 83
3.4.3 Bolivia 84
3.4.4 Brazil 85
3.4.5 Chile 86
3.4.6 Colombia 87
3.4.7 Costa Rica 87
3.4.8 Ecuador 88
3.4.9 El Salvador 88
3.4.10 Guatemala 89
3.4.11 Honduras 89
3.4.12 Mexico 90
3.4.13 Nicaragua 91
3.4.14 Panama 91
3.4.15 Paraguay 92
3.4.16 Peru 92
3.4.17 Uruguay 93
3.4.18 Venezuela 94
3.5 North America & the Caribbean: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding 94
3.5.1 Executive Summary 94
3.5.2 Barbados 97
3.5.3 Canada 98
3.5.4 Cuba 99
3.5.5 Dominican Republic 99
3.5.6 the Bahamas 99
3.5.7 the Netherlands Antilles 100
3.5.8 the United States 101
3.6 Oceana: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and 102
3.6.1 Executive Summary 102
3.6.2 Australia 105
3.6.3 New Zealand 106
3.7 the Middle East: Export Supplies of Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and 106
3.7.1 Executive Summary 106
3.7.2 Afghanistan 109
3.7.3 Iran 109
3.7.4 Israel 110
3.7.5 Jordan 111
3.7.6 Pakistan 112
3.7.7 Saudi Arabia 112
3.7.8 Syrian Arab Republic 113
3.7.9 the United Arab Emirates 113
3.7.10 Turkey 114
4 IMPORTS 115
4.1 Africa: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 115
4.1.1 Executive Summary 115
4.1.2 Algeria 120
4.1.3 Botswana 121
4.1.4 Cameroon 122
4.1.5 Cape Verde 123
4.1.6 Cote dIvoire 123
4.1.7 Egypt 124
4.1.8 Ethiopia 125
4.1.9 Gabon 125
4.1.10 Ghana 126
4.1.11 Madagascar 126
4.1.12 Malawi 127
4.1.13 Mauritania 127
4.1.14 Mauritius 128
4.1.15 Morocco 129
4.1.16 Mozambique 130
4.1.17 Namibia 130
4.1.18 Senegal 131
4.1.19 South Africa 132
4.1.20 Sudan 133
4.1.21 Tanzania 134
4.1.22 the Gambia 134
4.1.23 Uganda 135
4.2 Asia: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 2009 135
4.2.1 Executive Summary 135
4.2.2 Brunei 138
4.2.3 China 139
4.2.4 Hong Kong 140
4.2.5 India 141
4.2.6 Indonesia 142
4.2.7 Japan 143
4.2.8 Macau 144
4.2.9 Malaysia 145
4.2.10 Maldives 146
4.2.11 Mongolia 146
4.2.12 Philippines 147
4.2.13 Singapore 148
4.2.14 South Korea 149
4.2.15 Taiwan 150
4.2.16 Thailand 151
4.3 Europe: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 152
4.3.1 Executive Summary 152
4.3.2 Albania 157
4.3.3 Austria 158
4.3.4 Belarus 159
4.3.5 Belgium 160
4.3.6 Bosnia and Herzegovina 161
4.3.7 Bulgaria 162
4.3.8 Croatia 163
4.3.9 Cyprus 164
4.3.10 Czech Republic 165
4.3.11 Denmark 166
4.3.12 Estonia 167
4.3.13 Finland 168
4.3.14 France 169
4.3.15 Georgia 170
4.3.16 Germany 171
4.3.17 Greece 172
4.3.18 Hungary 173
4.3.19 Iceland 174
4.3.20 Ireland 175
4.3.21 Italy 176
4.3.22 Kazakhstan 177
4.3.23 Latvia 178
4.3.24 Lithuania 179
4.3.25 Luxembourg 180
4.3.26 Macedonia 180
4.3.27 Malta 181
4.3.28 Moldova 182
4.3.29 Norway 183
4.3.30 Poland 184
4.3.31 Portugal 185
4.3.32 Romania 186
4.3.33 Russia 187
4.3.34 Slovakia 188
4.3.35 Slovenia 189
4.3.36 Spain 190
4.3.37 Sweden 191
4.3.38 Switzerland 192
4.3.39 the Netherlands 193
4.3.40 the United Kingdom 194
4.3.41 Ukraine 195
4.4 Latin America: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports 196
4.4.1 Executive Summary 196
4.4.2 Argentina 199
4.4.3 Belize 200
4.4.4 Bolivia 201
4.4.5 Brazil 202
4.4.6 Chile 203
4.4.7 Colombia 204
4.4.8 Costa Rica 205
4.4.9 Ecuador 206
4.4.10 El Salvador 207
4.4.11 Guatemala 208
4.4.12 Guyana 209
4.4.13 Honduras 210
4.4.14 Mexico 211
4.4.15 Nicaragua 212
4.4.16 Panama 213
4.4.17 Paraguay 214
4.4.18 Peru 215
4.4.19 Uruguay 216
4.4.20 Venezuela 217
4.5 North America & the Caribbean: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and 218
4.5.1 Executive Summary 218
4.5.2 Barbados 221
4.5.3 Canada 222
4.5.4 Jamaica 223
4.5.5 St. Kitts and Nevis 223
4.5.6 the United States 224
4.5.7 Trinidad and Tobago 225
4.6 Oceana: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Imports in 225
4.6.1 Executive Summary 225
4.6.2 Australia 229
4.6.3 Fiji 230
4.6.4 New Caledonia 230
4.6.5 New Zealand 231
4.7 the Middle East: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins 231
4.7.1 Executive Summary 232
4.7.2 Armenia 235
4.7.3 Azerbaijan 236
4.7.4 Bahrain 236
4.7.5 Iran 237
4.7.6 Israel 237
4.7.7 Jordan 238
4.7.8 Kyrgyzstan 239
4.7.9 Oman 240
4.7.10 Pakistan 241
4.7.11 Qatar 242
4.7.12 Saudi Arabia 243
4.7.13 Syrian Arab Republic 244
4.7.14 Turkey 245
4.7.15 Yemen 245
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 246
5.1 Disclaimers & Safe Harbor 246
5.2 ICON Group Ltd. User Agreement Provisions 247
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
